A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP)

Sarah H. O'Brien, A. Kim Ritchey, Kenneth J. Smith

DOI: 10.1002/pbc.20830
Referenced 23 times
Share this paper
Use this link to share this page publicly